Exelon and Lortab drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Exelon (rivastigmine tartrate) and Lortab (acetaminophen; hydrocodone bitartrate). Common drug interactions include atrial fibrillation among females and pyelonephritis among males.

The phase IV clinical study analyzes what interactions people have when they take Exelon and Lortab. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Exelon?

Exelon has active ingredients of rivastigmine tartrate. It is often used in alzheimer's disease. eHealthMe is studying from 11,060 Exelon users. Check the latest studies of Exelon.

What is Lortab?

Lortab has active ingredients of acetaminophen; hydrocodone bitartrate. It is often used in pain. eHealthMe is studying from 31,285 Lortab users. Check the latest studies of Lortab.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

32 people who take Exelon and Lortab together, and have interactions are studied.

Exelon and Lortab drug interactions.

What are the common drug interactions of Exelon and Lortab, by gender? *:

female:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Atrial tachycardia (rhythm disturbance that arises in the atria)
  3. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  4. Bedridden
  5. Blood urea nitrogen/creatinine ratio increased
  6. Blood urine present
  7. Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
  8. Cardiomegaly (increased size of heart than normal)
  9. Carotid artery stenosis (narrowing of carotid artery)
  10. Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)

male:

  1. Pyelonephritis (inflammation of kidney caused by bacteria)
  2. Urinary retention (the inability to completely or partially empty the bladder)
  3. Angina pectoris (chest pain due to ischemia of the heart muscle)
  4. Blood glucose decreased
  5. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  6. Chest pain
  7. Drug ineffective
  8. Fall
  9. Foot fracture
  10. Influenza

What are the common drug interactions of Exelon and Lortab, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Pyelonephritis (inflammation of kidney caused by bacteria)
  2. Urinary retention (the inability to completely or partially empty the bladder)
  3. Arm amputation
  4. Atrioventricular dissociation (av block)
  5. Cardiomyopathy (weakening of the heart muscle)
  6. Dizziness
  7. Femur fracture
  8. Hepatic failure (liver failure)
  9. Hip fracture
  10. Impaired healing

What are the existing conditions these people have? *

  1. Osteoporosis (bones weak and more likely to break): 9 people, 28.12%
  2. Diabetes: 8 people, 25.00%
  3. Urinary Incontinence (inability to control the flow of urine and involuntary urination): 7 people, 21.88%
  4. Non-Small Cell Lung Cancer Stage Iv: 3 people, 9.38%
  5. Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 3 people, 9.38%
  6. Migraine (headache): 3 people, 9.38%
  7. Indigestion: 3 people, 9.38%
  8. Dementia (madness): 3 people, 9.38%
  9. Dyspnea (difficult or laboured breathing): 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Exelon and Lortab?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Exelon and Lortab:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Exelon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lortab:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Exelon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lortab and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on rivastigmine tartrate and acetaminophen; hydrocodone bitartrate (the active ingredients of Exelon and Lortab, respectively), and Exelon and Lortab (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: